News | Artificial Intelligence | April 08, 2021

Company will work closely with Google Cloud and build AI tools for radiation oncology organ segmentation using the Google Cloud AI Platform

Varian announced it is collaborating with Google Cloud to build an advanced artificial intelligence (AI) based diagnostic platform to aid in the fight against cancer. Varian and Google Cloud AI embarked on a deployment journey, using Neural Architecture Search (NAS) technology via Google Cloud AI Platform, to create AI models for organ segmentation — a crucial and labor-intensive step in radiation oncology that can be a bottleneck in the cancer treatment clinical workflow.

April 8, 2021 — Varian announced it is collaborating with Google Cloud to build an advanced artificial intelligence (AI) based diagnostic platform to aid in the fight against cancer. Varian and Google Cloud AI embarked on a deployment journey, using Neural Architecture Search (NAS) technology via Google Cloud AI Platform, to create AI models for organ segmentation — a crucial and labor-intensive step in radiation oncology that can be a bottleneck in the cancer treatment clinical workflow.

Organ segmentation is the process of identifying the organs and tissues in diagnostic images that must be targeted or protected during a course of radiation therapy. These segmented images are then used to create radiotherapy treatment plans that specify where and how much dose will be deposited during treatment. This is a labor-intensive process that can take a clinician hours per patient. In some regions of the world, segmentation is a limiting factor in cancer patients' access to advanced treatments like intensity-modulated radiotherapy (IMRT) that require accurate organ segmentation.

Varian is using Google Cloud AI Platform's NAS technology to create an AI segmentation engine that is being "trained," using Varian's proprietary treatment planning image data, to create customized auto-segmentation models for organs in the body. Varian intends to incorporate these models into its treatment planning software tools for use in cancer centers around the world.

"At Varian, we are working towards a world without fear of cancer, where high-quality cancer care — personalized and optimized for each patient — is available everywhere. To that end, we have committed ourselves to Intelligent Cancer Care, which seeks to automate routine or repetitive tasks in the radiation oncology workflow through the use of smart algorithms, machine learning, and AI," said Corey Zankowski,Ph.D., Senior Vice President, Technology and Innovation Office, Varian. "This collaboration with Google Cloud will turbocharge our efforts in this area."

"At Google Cloud, we believe AI technology has the power to impact a wide variety of industries, which is especially true in the field of medicine," said Craig Wiley, Director of Product Management, Google Cloud. "We are excited to see how Varian accelerates AI innovation and segmentation quality to improve cancer care with radiation therapy using our state-of-the-art NAS technology. As Varian's AI platform of choice, our teams are working closely to deliver best-in-class AI for cancer treatment to patients around the world."

For more information: www.varian.com


Related Content

News | Stroke

Dec. 18, 2025 — Brainomix, a provider of AI-powered imaging biomarkers for stroke and lung fibrosis, has announced ...

Time December 24, 2025
arrow
News | Information Technology

Dec. 16, 2025 — McCrae Tech has launched the world’s first health AI orchestrator called Orchestral. It is a health ...

Time December 23, 2025
arrow
News | RSNA 2025

Dec. 12, 2025 — At RSNA 2025, United Imaging Intelligence (UII), the AI-focused subsidiary of United Imaging Group ...

Time December 17, 2025
arrow
News | Breast Imaging

Dec. 16, 2025 — Hologic, Inc, a medical technology company dedicated to improving women’s health, recently announced new ...

Time December 16, 2025
arrow
News | Radiopharmaceuticals and Tracers

Dec. 11, 2025 — Telix Pharmaceuticals Ltd. has announced a strategic clinical collaboration with Varian, a Siemens ...

Time December 11, 2025
arrow
Feature | Radiation Oncology | Kyle Hardner

Genomics has guided personalized cancer treatments for the past two decades. Now, AI biomarkers are expanding the field ...

Time December 09, 2025
arrow
News | FDA

Dec. 02, 2025 — Alpha Tau Medical Ltd., the developer of the alpha-radiation cancer therapy Alpha DaRT, has announced ...

Time December 04, 2025
arrow
News | Women's Health

Dec. 1, 2025 — ScreenPoint Medical has completed a commercial agreement making its Transpara breast-imaging AI portfolio ...

Time December 03, 2025
arrow
News | Information Technology

Dec. 1, 2025 — BioSked has announced a major expansion of its Momentum scheduling platform, introducing one of the first ...

Time December 03, 2025
arrow
News | Radiology Imaging

Dec. 1, 2025 — Rad AI has launched next-generation speech recognition technology (patent pending) that dramatically ...

Time December 02, 2025
arrow
Subscribe Now